The endocrinology of adrenal tuberculosis: The effects of tuberculosis on the hypothalamo-pituitary-adrenocortical function

Journal of Endocrinological Investigation

Volumn 27, Issue 4, 2004, Pages 380-386

  Kelestimur, F ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

ACTH test; Addison; Adrenal; HP axis; Tuberculosis

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GAMMA INTERFERON; HYDROCORTISONE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 5; INTERLEUKIN 6; PRASTERONE; RIFAMPICIN; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADDISON DISEASE; ADRENAL CORTEX FUNCTION; ADRENAL DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CORTICOTROPIN TEST; CYTOKINE PRODUCTION; ENDOCRINE GLAND; ENDOCRINE SYSTEM EXAMINATION; HISTOPATHOLOGY; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PATHOPHYSIOLOGY; SHORT SURVEY; TH1 CELL; TH2 CELL;

EID: 2942615151     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03351067     Document Type: Short Survey

References (62)

1. Martin G, Lazarus A. Epidemiology and diagnosis of tuberculosis. Postgrad Med 2000, 108: 42-54.
2. Raviglione MC, Snider DE Jr, Kochi A. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA 1995, 273: 220-6.
3. WHO report. Global Tuberculosis Programme. Geneva. 1998.
4. Kelestimur F, Güven M, Pasaoglu H, Özesmi M. Does tuberculosis really cause hypercalcemia? J Endocrinol Invest 1996, 19: 678-81.
5. Addison T. On the constitutional and local effects of disease of the supra-renal capsules. London: Highley. 1855.
6. Drury PL, Besser GM. Adrenal cortex. In: Hall R, Besser GM eds. Fundamentals of clinical endocrinology. Edinburgh: Churchill Livingstone. 1989, 153.
7. Guttman PH. Addison's disease: a statistical analysis of 566 cases and a study of the pathology. Arch Pathol 1930, 10: 742-85.
8. Sanford JP, Favour CB. The interrelationships between Addison's disease and active tuberculosis: a review of 125 cases of Addison's disease. Ann Intern Med 1956, 45: 56-72.
9. Stuart-Mason SA, Meade TW, Lee JAH, Morris JN. Epidemiological and clinical picture of Addison's disease. Lancet 1968, 2: 744-7.
10. De Rosa G, Corsello SM, Cecchini L, Della Casa S, Testa A. A clinical study of Addison's disease. Exp Clin Endocrinol Diabetes 1987, 90: 232-42.
11. Soule S. Addison's disease in Africa - a teaching hospital experience. Clin Endocrinol (Oxf) 1999, 50: 115-20.
12. Marie-France K, Jeffkoate W. Eighty-six cases of Addison's disease. Clin Endocrinol (Oxf) 1994, 41: 757-61.
13. Huebener KH, Treugut H. Adrenal cortex dysfunction: CT findings. Radiology 1984, 150: 195-9.
14. Lam KY, Lo CY. A critical examination of adrenal tuberculosis and a 28-year autopsy experience of active tuberculosis. Clin Endocrinol (Oxf) 2001, 54: 633-9.
15. Sun ZH, Nomura K, Toraya S, et al. Clinical significance of adrenal computed tomography in Addison's disease. Endocrinol Jpn 1992, 39: 563-9.
16. Vita JA, Silverberg SJ, Goland RS, Austin JHM, Knowlton AI. Clinical clues to the cause of Addison's disease. Am J Med 1985, 78: 461-6.
17. Kelestimur F, Özbakir Ö, Saglam A, Öztürk F, Yücesoy M. Acute adrenocortical failure due to tuberculosis. J Endocrinol Invest 1993, 16: 281-4.
18. McMurry JF, Lond D, McClure R, Kotchen TA. Addison's disease with adrenal enlargement on computed tomography scanning. Report of two cases of tuberculosis and review of the literature. Am J Med 1984, 77: 365-8.
19. Jayakar DV, Giuseppe C, DeSoto-LaPaix F, Plawker M, Farag A, Ghosh BC. Adrenal tuberculosis. Eur J Surg 1998, 164: 975-8.
20. Penrice J, Nussey SS. Recovery of adrenocortical function following treatment of tuberculous Addison's disease. Postgrad Med J 1992, 68: 204-5.
21. Kelestimur F. Recovery of adrenocortical function following treatment of tuberculous Addison's disease. Postgrad Med J 1993, 69: 832.
22. Villabona CM, Sahun M, Ricart W, et al. Tuberculous Addison's disease. Utility of CT in diagnosis and follow-up. Eur J Radiol 1993, 17: 210-3.
23. Reznek RH, Armstrong P. The adrenal gland. Clin Endocrinol (Oxf) 1994, 40: 561-76.
24. Oelkers W. Adrenal insufficiency. N Engl J Med 1996, 335: 1206-12.
25. Bhatia E, Jain SK, Grupta RK, Pandey R. Tuberculous Addison's disease: lack of normalization of adrenocortical function after anti-tuberculous chemotherapy. Clin Endocrinol (Oxf) 1998, 48: 355-9.
26. Moss CN, England ML, Kowal J. Adrenal insufficiency (Addison's disease) in the elderly. J Am Geriatr Soc 1985, 33: 63-8.
27. Wilkins EGL, Hnizdo E, Cope A. Addisonian crisis induced by treatment with rifampicin. Tubercle 1989, 70: 69-73.
28. Elansary EH, Earis JE. Rifampicin and adrenal crisis. Br Med J 1983, 286: 1861-2.
29. Kyriazopoulou V, Parparousi O, Vagenakis AG. Rifampicin-induced adrenal crisis in Addisonian patients receiving corticosteroid replacement therapy. J Clin Endocrinol Metab 1984, 59: 1204-6.
30. Ünlühizarci K, Yildiz O, Aygen B, Bayram F, Kelestimur F. Rifampicin induced acute adrenal crisis in a patient with miliary tuberculosis. 5th European Congress of Endocrinology, Turin, 2001, p. 8 (abstract).
31. Kelestimur F, Ünlü Y, Özesmi M, Tolu I. A hormonal and radiological evaluation of adrenal gland in patients with acute or chronic pulmonary tuberculosis. Clin Endocrinol (Oxf) 1994, 41: 53-6.
32. Ellis ME, Tayoub F. Adrenal functions in tuberculosis. Br J Dis Chest 1986, 80: 7-12.
33. Barnes DJ, Naragi S, Temu P, Turtle JR. Adrenal function in patients with active tuberculosis. Thorax 1989, 44: 422-4.
34. Sarma GR, Immanuel C, Ramachandran G, Krishnamurthy PV, Kumaraswami V, Prabhakar R. Adrenocortical function in patients with pulmonary tuberculosis. Tubercle 1990, 71: 277-82.
35. Hawken MP, Ojoo JCO, Morris JS, et al. No increased prevalence of adrenocortical insufficiency in human immunodeficiency virus-associated tuberculosis. Tuber Lung Dis 1996, 77: 444-8.
36. May EE, Carey RM. Rapid adrenocorticotropic hormone test in practice. Am J Med 1985, 79: 679-84.
37. Kelestimur F, Akgün A, Günay O. A comparison between short synacthen test and depot synacthen test in the evaluation of cortisol reserve of adrenal gland in normal subjects. J Endocrinol Invest 1995, 18: 823-6.
38. Mayenknecht J, Diederich S, Bahr V, Plockinger U, Oelkers W. Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease. J Clin Endocrinol Metab 1998, 83: 1558-62.
39. Kelestimur F. Adrenocortical function in active pulmonary tuberculosis. Int J Tuberc Lung Dis 1998, 2: 172-4.
40. Kukreja SC, Williams GA. Corticotropin stimulation test: inverse correlation between basal serum cortisol and its response to corticotropin. Acta Endocrinol (Copenh) 1981, 97: 522-4.
41. Post FA, Soule SG, Willcox PA, Lewitt NS. The spectrum of endocrine dysfunction in active pulmonary tuberculosis. Clin Endocrinol (Oxf) 1994, 40: 367-71.
42. Rasmuson S, Olsson T, Hagg E. A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol (Oxf) 1996, 44: 151-6.
43. Dökmetas HS, Çolak R, Kelestimur F, Selçuklu A, Ünlühizarci K, Bayram F. A comparison between the 1μg adrenocorticotropin (ACTH) test, the short ACTH (250 μg) test, and the insulin tolerance test in the assessment of hypothalamopituitary-adrenal axis immediately after pituitary surgery. J Clin Endocrinol Metab 2000, 85: 3713-9.
44. Dickstein G, Shechner C, Nicholson WE, et al. Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test. J Clin Endocrinol Metab 1991, 72: 773-8.
45. Kelestimur F, Göktas Z, Gülmez I, et al. Low dose (1 μg) adrenocorticotropin stimulation test in the evaluation of the hypothalamo-pituitary-adrenal axis in patients with active pulmonary tuberculosis. J Endocrinol Invest 2000, 23: 235-9.
46. York EL, Enarson DA, Nobert EJ, Fanning A, Sproule BJ. Adrenocortical function in patients investigated for active tuberculosis. Chest 1992, 101: 1338-41.
47. Gülmez S, Kelestimur F, Durak AC, Özesmi M. Changes in the size of adrenal glands in acute pulmonary tuberculosis with therapy. Endocr J 1996, 43: 573-6.
48. Hernandez-Pando R, Orozco H, Honour J, Silva P, Leyva R, Rook GA. Adrenal changes in munine pulmonary tuberculosis: a clue to pathogenesis? FEMS Immunol Med Microbiol 1995, 12: 63-72.
49. Gaillard R.C. Neuroendocrine-immune system interactions: the immune-hypothalamo-pituitary-adrenal axis. Trends Endocrinol Metab 1994, 5: 303-9.
50. Fukata J, Imura H, Nakao K. Cytokines as mediators in the regulation of the hypothalamic-pituitary-adrenocortical function. J Endocrinol Invest 1993, 16: 141-55.
51. Egdahl R, Melby JC, Spink WW. Adrenal cortical and body temperature responses to repeated endotoxin administration. Proc Soc Exp Biol Med 1959, 101: 369-72.
52. Pozzoli G, Costa A, Grimaldi M, et al. Lipopolysaccharide modulation of eicosanoid and corticotrophin-releasing hormone release from rat hypothalamic explants and astrocyte cultures in vitro: evidence forthe involvement of prostaglandin E2 but not prostaglandin F2α and lack of effect of nerve growth factor. J Endocrinol 1994, 140: 103-9.
53. Perlstein RS, Whitnall MH, Abrams JS, Mougey EH, Neta R. Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology 1993, 132: 949-52.
54. Mandrup-Poulsen T, Nerup J, Reimers JI, et al. Cytokines and the endocrine system. I. The immunoendocrine network. Eur J Endocrinol 1995, 133: 660-71.
55. Zhang Y, Doerfler M, LeeTC, Guillemir B, Rom WN. Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by mycobacterium tuberculosis components. J Clin Invest 1993, 91: 2076-83.
56. Barnes PF, Abrams JS, Lu S, Sieling PA, Rea TH, Modlin R. Patterns of cytokine production by mycobacterium-reactive human T-cell clones. Infect Immun 1993, 61: 197-203.
57. Rook GAW, Hernandez-Pando R. Immunological and endocrinological characteristics of tuberculosis that provide opportunities for immunotherapeutic intervention. In: Genetics and tuberculosis. Novartis Foundation Symposium. Chichester: Wiley. 1988, 73.
58. Rook GAW, Hernandez-Pando R, Lightman SL. Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. Immunol Today 1994, 15: 301-3.
59. Blauer KL, Poth M, Rogers WM, Bernton EW. Dehydroepiandrosterone antagonises the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology 1991, 129: 3174-9.
60. Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984, 59: 551-5.
61. Donald PR, Beyers N, Rook GAW. Adolescent tuberculosis. S Afr Med J 1996, 86: 231-3.
62. Keven K, Uysal AR, Erdogan G. Adrenal function during tuberculous infection and effects of antituberculosis treatment on endogenous and exogenous steroids. Int J Tuberc Lung Dis 1998, 2: 419-24.